Treatment of Late Latent Syphilis with Positive CSF VDRL
A positive CSF VDRL confirms neurosyphilis and mandates treatment with intravenous aqueous crystalline penicillin G 18-24 million units per day (administered as 3-4 million units IV every 4 hours or continuous infusion) for 10-14 days. 1
Primary Treatment Regimen
The diagnosis of neurosyphilis with a positive CSF VDRL requires immediate escalation from standard late latent syphilis therapy to a neurosyphilis-specific regimen:
- Aqueous crystalline penicillin G 18-24 million units per day IV, given either as 3-4 million units every 4 hours or as continuous infusion, for 10-14 days 1
- This regimen ensures continuous treponemicidal penicillin concentrations in CSF throughout treatment, which is essential for eradicating CNS infection 2
Alternative Regimen (If Compliance Assured)
If outpatient compliance can be guaranteed, an alternative exists:
- Procaine penicillin 2.4 million units IM once daily PLUS Probenecid 500 mg orally four times daily, both for 10-14 days 1
- This combination achieves adequate CSF penicillin levels through probenecid's blockade of renal tubular secretion 1
Critical Post-Treatment Consideration
Because neurosyphilis regimens are shorter than late latent syphilis treatment, many specialists recommend supplemental benzathine penicillin G 2.4 million units IM weekly for 3 weeks after completing the neurosyphilis regimen to provide comparable total treatment duration 1
Penicillin Allergy Management
For penicillin-allergic patients, the approach differs significantly from non-neurologic syphilis:
- Penicillin desensitization followed by standard penicillin therapy is the preferred approach 1
- Ceftriaxone 2 grams daily (IM or IV) for 10-14 days may be considered as an alternative, though cross-reactivity with penicillin exists and efficacy data are limited 1
- Doxycycline and tetracycline are NOT adequate for neurosyphilis and should never be used 3
Important caveat: Patients with sulfa allergies should not receive the procaine penicillin/probenecid alternative, as they are likely allergic to probenecid 1
Mandatory Follow-Up Protocol
CSF monitoring is essential to confirm treatment success:
- Repeat CSF examination at 3 and 6 months after treatment completion, then every 6 months until CSF white blood cell count normalizes and CSF-VDRL becomes nonreactive 1
- If CSF pleocytosis was present initially, the cell count must normalize; if it hasn't decreased after 6 months or isn't normal after 2 years, re-treatment should be considered 1
- Serum nontreponemal tests (RPR/VDRL) should be monitored at 3,6,9,12, and 24 months, with at least a fourfold decline expected 1
HIV Co-infection Considerations
HIV status significantly impacts treatment response and monitoring:
- All patients with syphilis must be tested for HIV 1
- HIV-infected patients may have poorer CSF and serologic responses to neurosyphilis therapy 1, 4
- More frequent monitoring is required for HIV-positive patients, with evaluations at 3-month intervals rather than 6-month intervals 1
- Some data suggest that standard penicillin regimens may not be consistently effective in HIV-infected patients with neurosyphilis 4
Treatment Failure Indicators
Re-treatment should be considered if:
- CSF cell count has not decreased after 6 months of follow-up 1
- CSF is not normal after 2 years 1
- Serum nontreponemal titers fail to decline at least fourfold within 12-24 months 1
- Clinical signs or symptoms of neurosyphilis persist or recur 1
Common Pitfalls to Avoid
- Never treat confirmed neurosyphilis with benzathine penicillin alone—it does not achieve adequate CSF levels 1
- Do not use oral antibiotics (doxycycline, tetracycline, azithromycin) for neurosyphilis—they are inadequate for CNS infection 3, 5
- Do not skip CSF follow-up examinations—they are the only way to confirm treatment success in neurosyphilis 1
- In pregnant patients with neurosyphilis and penicillin allergy, desensitization is mandatory—no alternative antibiotics reliably treat neurosyphilis or prevent congenital syphilis 1